Michael Bookman, General Counsel and Secretary at Immuneering Corp (IMRX), bought 1,402 shares at $15.00 ($21K) on 2021-08-03, disclosed to the SEC on 2021-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |